financetom
Business
financetom
/
Business
/
NMI "Well Positioned" in Mortgage Insurance Market Despite Macroeconomic Challenges, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NMI "Well Positioned" in Mortgage Insurance Market Despite Macroeconomic Challenges, RBC Says
Sep 22, 2024 1:53 PM

11:24 AM EDT, 09/18/2024 (MT Newswires) -- NMI Holdings ( NMIH ) is "well positioned" in the mortgage insurance market relative to its peers despite macroeconomic challenges, RBC Capital Markets said in a note Tuesday.

Nearly 50% of NMI's risk exposure involves borrowers with FICO scores above 760, and its default rate is under 1%, significantly better than peers who have default rates ranging between 1.5% and 2.5%, the investment firm said.

NMI's risk-based pricing model helps the company assess and price risk more effectively, ensuring robust protection and maintaining favorable underwriting results in a challenging housing market, RBC added.

NMI continues to be active in share buybacks and is expected to potentially introduce a quarterly dividend. The company's "healthy capital position" supports these capital return initiatives, the RBC analysts said.

In an upside scenario, NMI's stock price could reach $55, supported by earned premium growth of more than 10% and a 29.5% combined ratio. On the other hand, in a downside scenario, the price could fall to $32 if economic conditions worsen, leading to higher loss ratios and slower growth, RBC said.

RBC raised its rating to outperform from sector perform and boosted the price target to $48 from $40.

Price: 42.00, Change: +0.85, Percent Change: +2.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech, Duality Biologics Receive FDA Fast-Track Designation for Prostate Cancer Drug
BioNTech, Duality Biologics Receive FDA Fast-Track Designation for Prostate Cancer Drug
Jun 24, 2024
08:05 AM EDT, 06/24/2024 (MT Newswires) -- BioNTech (BNTX) and Duality Biologics said Monday that the US Food and Drug Administration has granted fast-track designation for their experimental drug, BNT324/DB-1311, to treat metastatic castration-resistant prostate cancer. The designation, which facilitates the development and expedites the review of new drugs and vaccines, was based on preliminary safety and efficacy data from...
Oshkosh Secures $27.3 Million US Army Order for Medium Equipment Trailers
Oshkosh Secures $27.3 Million US Army Order for Medium Equipment Trailers
Jun 24, 2024
08:04 AM EDT, 06/24/2024 (MT Newswires) -- Oshkosh (OSK) unit Oshkosh Defense said Monday that it secured a $27.3 million order for 57 medium equipment trailers from the US Army Contracting Command - Detroit Arsenal. The company said it plans to execute the order with its partner Broshuis B.V. Price: 107.53, Change: -0.02, Percent Change: -0.02 ...
Enbridge Joins First Nations to Advance Wind Energy Project in Saskatchewan
Enbridge Joins First Nations to Advance Wind Energy Project in Saskatchewan
Jun 24, 2024
08:01 AM EDT, 06/24/2024 (MT Newswires) -- Enbridge ( ENB ) said on Monday that it teamed up with Six Nations Energy Development, a newly created consortium of First Nations, to develop the 200-megawatt Seven Stars wind energy project in Saskatchewan. Enbridge ( ENB ) said the project will be able to support the annual energy needs of over 100,000...
Progyny Acquires Germany's Apryl, Adds Fertility Benefits to Global Services
Progyny Acquires Germany's Apryl, Adds Fertility Benefits to Global Services
Jun 24, 2024
08:02 AM EDT, 06/24/2024 (MT Newswires) -- Progyny ( PGNY ) said Monday it acquired Germany's Apryl, a fertility benefits platform, adding fertility and family-building benefits to Progyny's ( PGNY ) concierge support for employees. Progyny ( PGNY ) said its global services following the deal now include enhanced support across preconception, fertility, fertility treatments, adoption, and surrogacy. Financial details...
Copyright 2023-2026 - www.financetom.com All Rights Reserved